These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 16503077)

  • 41. [Regulations in the classification of primary liver neoplasms].
    Kasai Y; Sugahara K
    Nihon Rinsho; 1982; 40(1):15-25. PubMed ID: 6283200
    [No Abstract]   [Full Text] [Related]  

  • 42. Usefulness of the HKLC vs. the BCLC staging system in a European HCC cohort.
    Adhoute X; Penaranda G; Bronowicki JP; Raoul JL
    J Hepatol; 2015 Feb; 62(2):492-3. PubMed ID: 25194894
    [No Abstract]   [Full Text] [Related]  

  • 43. A novel prognostic nomogram is more accurate than conventional staging systems for predicting survival after resection of hepatocellular carcinoma.
    Cho CS; Gonen M; Shia J; Kattan MW; Klimstra DS; Jarnagin WR; D'Angelica MI; Blumgart LH; DeMatteo RP
    J Am Coll Surg; 2008 Feb; 206(2):281-91. PubMed ID: 18222381
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Usefulness of the CLIP scoring system for prediction of postoperative prognosis of patients with large hepatocellular carcinoma.
    Noda T; Sasaki Y; Yamada T; Eguchi H; Yano M; Ohigashi H; Ishikawa O; Imaoka S
    J Hepatobiliary Pancreat Surg; 2009; 16(4):538-45. PubMed ID: 19367360
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of 7 staging systems for patients with hepatocellular carcinoma undergoing transarterial chemoembolization.
    Tez M; Zulfikaroglu B
    Cancer; 2008 Jun; 112(12):2820-1; author reply 2821. PubMed ID: 18465802
    [No Abstract]   [Full Text] [Related]  

  • 46. Treatment of stage IVA hepatocellular carcinoma.
    Palavecino M; Wittekind C; Vauthey JN
    Arch Surg; 2008 Dec; 143(12):1235-6; author reply 1236. PubMed ID: 19075180
    [No Abstract]   [Full Text] [Related]  

  • 47. [Therapy of primary hepatocellular carcinoma].
    Jonas S; Bechstein WO; Kling N; Guckelberger O; Neuhaus P
    Dtsch Med Wochenschr; 1997 May; 122(19):617-20. PubMed ID: 9182027
    [No Abstract]   [Full Text] [Related]  

  • 48. [Hepatocellular carcinoma].
    Lauchart W
    Zentralbl Chir; 1994; 119(11):751-2. PubMed ID: 7846953
    [No Abstract]   [Full Text] [Related]  

  • 49. Comparison of seven prognostic staging systems in patients who undergo hepatectomy for hepatocellular carcinoma.
    Kondo K; Chijiiwa K; Nagano M; Hiyoshi M; Kai M; Maehara N; Ohuchida J; Nakao H; Ohkuwa Y
    Hepatogastroenterology; 2007; 54(77):1534-8. PubMed ID: 17708292
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The efficacy of treatment schedules according to Barcelona Clinic Liver Cancer staging for hepatocellular carcinoma - Survival analysis of 3892 patients.
    Wang JH; Changchien CS; Hu TH; Lee CM; Kee KM; Lin CY; Chen CL; Chen TY; Huang YJ; Lu SN
    Eur J Cancer; 2008 May; 44(7):1000-6. PubMed ID: 18337087
    [TBL] [Abstract][Full Text] [Related]  

  • 51. More options and improved outcomes for hepatocellular carcinoma.
    Scoggins CR
    J Surg Oncol; 2008 Aug; 98(2):74. PubMed ID: 18623036
    [No Abstract]   [Full Text] [Related]  

  • 52. [Diagnostic imaging and therapy of hepatocellular carcinoma].
    Allgaier HP; Deibert P; Blum HE
    Dtsch Med Wochenschr; 1997 Dec; 122(50):1573-5. PubMed ID: 9445781
    [No Abstract]   [Full Text] [Related]  

  • 53. Impact of current staging systems on treatment strategy for HBV-related hepatocellular carcinoma.
    Yan X; Qiu Y
    Cancer Lett; 2016 Sep; 379(2):220-4. PubMed ID: 26282785
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): the role of angiogenesis and invasiveness.
    Sergio A; Cristofori C; Cardin R; Pivetta G; Ragazzi R; Baldan A; Girardi L; Cillo U; Burra P; Giacomin A; Farinati F
    Am J Gastroenterol; 2008 Apr; 103(4):914-21. PubMed ID: 18177453
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Management of hepatocellular carcinoma.
    Del Pozo AC; López P
    Clin Liver Dis; 2007 May; 11(2):305-21. PubMed ID: 17606209
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of 7 staging systems for patients with hepatocellular carcinoma undergoing transarterial chemoembolization.
    Cho YK; Chung JW; Kim JK; Ahn YS; Kim MY; Park YO; Kim WT; Byun JH
    Cancer; 2008 Jan; 112(2):352-61. PubMed ID: 18008352
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of staging systems for HCC: one more positive answer or mission impossible?
    Huo TI; Wu JC; Lee SD
    Hepatology; 2005 Jul; 42(1):238-9. PubMed ID: 15962309
    [No Abstract]   [Full Text] [Related]  

  • 58. Interobserver and intraobserver variability in evaluating vascular invasion in hepatocellular carcinoma.
    Fan L; Mac MT; Frishberg DP; Fan X; Dhall D; Balzer BL; Geller SA; Wang HL
    J Gastroenterol Hepatol; 2010 Sep; 25(9):1556-61. PubMed ID: 20796155
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Current approach to down-staging of hepatocellular carcinoma prior to liver transplantation.
    Hanje AJ; Yao FY
    Curr Opin Organ Transplant; 2008 Jun; 13(3):234-40. PubMed ID: 18685309
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Treatment for hepatocellular carcinoma under consideration of quality of life].
    Maeba T
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():801-6. PubMed ID: 11762060
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.